El Marroun, H, White, TJH, van der Knaap, NJF, Homberg, JR, Fernández, G, Schoemaker, NK, et al. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry
2014; 205: 95–102.
Rutter, M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr
2005; 94: 2–15.
Blaxill, MF. What's going on? The question of time trends in autism. Public Health Rep
2004; 119: 536–51.
Demicheli, V, Rivetti, A, Debalini, MG, Di Pietrantonj, C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev.
2012; 2: CD004407.
Happé, F, Ronald, A. The “fractionable autism triad”: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev
2008; 18: 287–304.
Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. In Lancet
2013; 381: 1371–9.
Petersen, I, Gilbert, RE, Evans, SJW, Man, S-L, Nazareth, I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry
2011; 72: 979–85.
Rai, D, Lee, BK, Dalman, C, Golding, J, Lewis, G, Magnusson, C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ
2013; 346: f2059.
Croen, LA. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry
2011; 68: 1104.
Howerton, CL, Morgan, CP, Fischer, DB, Bale, TL. O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development. Proc Natl Acad Sci USA
2013; 110: 5169–74.